The Impact of Momelotinib on Patient Reported Quality of Life for Symptomatic and Anemic Patients with Myelofibrosis: Results from the Phase 3 Momentum Study
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9677-9680
10.1182/blood-2022-162547